DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

EXACT Sciences Corp (NASDAQ: EXAS)

22.04 -0.95 (-4.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

EXAS $22.04 -4.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.16
Previous Close $22.99
Daily Range $21.88 - $23.22
52-Week Range $10.69 - $29.97
Market Cap $2.0B
P/E Ratio -18.39
Dividend (Yield) $0.00 (0.0%)
Volume 1,532,752
Average Daily Volume 1,419,806
Current FY EPS -$1.60




Drug Makers

EXACT Sciences Corp (EXAS) Description

An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer. Website:

News & Commentary Rss Feed

Pain-Free Blood Tests? Sign Me Up!

A small, Wisconsin-based company could be on the verge of developing a revolutionary new blood test that is virtually pain-free. Find out how personalized healthcare is transforming the medical field.

EXACT Sciences Breaks Below 200-Day Moving Average - Notable for EXAS

A Possible Glimpse Into the Future: Is a $1 Prostate Cancer Test on the Way?

A more accurate and significantly cheaper prostate cancer screening test? Find out what researchers at the University of Central Florida are up to -- and how it could transform prostate cancer diagnoses many years down the road.

In Case You Missed It, Obamacare Just Logged a Major Victory at the Supreme Court

It wasn't a high profile case, but Obamacare logged another legal victory this past week at the Supreme Court. However, it doesn't mean that Obamacare is out of the woods just yet.

Could Exact Sciences Corporation Really Be Worth $3 Billion?

Sometimes Wall Street analysts throw out some quirky price target estimates. Is one firm's price target of $34 per share, or $3 billion, one such fantastical claim, or could Exact Sciences actually hit this lofty target?

Exact (EXAS) Showing Signs Of A Dead Cat Bounce Today

Goldman Sachs Cuts Myriad Genetics To Sell, Ups Alere

Why Exact Sciences Corporation Is Dropping Today

Exact Sciences shares were cut to neutral today by Goldman Sachs.

Notable Two Hundred Day Moving Average Cross - EXAS

Exact Sciences Had Wildly Successful 2014, Can We Expect The Same In 2015?

See More EXAS News...

EXAS's Top Competitors

EXAS $22.04 (-4.13%)
Current stock: EXAS
AMGN $168.46 (1.50%)
Current stock: AMGN
GILD $105.20 (4.52%)
Current stock: GILD
BIIB $422.11 (-0.19%)
Current stock: BIIB